2/21/2012 - 3:40 PM EST - Paladin Labs Inc. : announced that it has entered into a strategic partnership whereby Paladin will accelerate its buy-out of the remaining 55.01% of Pharmaplan (Pty) Limited and merge the Pharmaplan business with the pharma division of Litha Healthcare Group Limited. This represents the most significant strategic corporate expansion initiative to date for Paladin and is a decisive move to build critical mass and competitive differentiation in the South African pharmaceutical market which is currently valued at over $3.3 billion (25.3 billion South African Rand, an increase of 10% over 2010. Paladin Labs Inc.
shares T.PLB are trading up $0.23 at $41.76.
